Have a personal or library account? Click to login

Showing 13-23 of 23 for the term ""Dolžan, Vita""

The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma
Article

The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma

Levpuscek, Kristina, Goricar, Katja, Kovac, Viljem, Dolzan, Vita, Franko, Alenka
The role of polymorphisms in glutathione-related genes in asbestos-related diseases
Article

The role of polymorphisms in glutathione-related genes in asbestos-related diseases

Franko, Alenka, Goricar, Katja, Dodic Fikfak, Metoda, Kovac, Viljem, Dolzan, Vita
Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases
Article

Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases

Mervic, Ana, Goricar, Katja, Blagus, Tanja, Franko, Alenka, Trebusak-Podkrajsek, Katarina, Fikfak, Metoda Dodic, Dolzan, Vita, Kovac, Viljem
Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
Article

Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence

Vodusek, Ana Lina, Goricar, Katja, Gazic, Barbara, Dolzan, Vita, Jazbec, Janez
Associations of NLRP3 and CARD8 gene polymorphisms with alcohol dependence and commonly related psychiatric disorders: a preliminary study
Article

Associations of NLRP3 and CARD8 gene polymorphisms with alcohol dependence and commonly related psychiatric disorders: a preliminary study

Ilješ, Anja Plemenitaš, Plesničar, Blanka Kores, Dolžan, Vita
Asbestosis and Catalase Genetic Polymorphism
Article

Asbestosis and Catalase Genetic Polymorphism

Franko, Alenka, Dolžan, Vita, Arnerić, Niko, Dodič-Fikfak, Metoda
Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
Article

Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma

Setina, Matic, Setina, Eva, Doljak, Ziga, Goricar, Katja, Dolzan, Vita, Kovac, Viljem
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
Article

Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma

Kovac, Viljem, Dodic-Fikfak, Metoda, Arneric, Niko, Dolzan, Vita, Franko, Alenka
A reflection after 24 „training the trainers“ workshops
Article

A reflection after 24 „training the trainers“ workshops

Rener-Primec, Zvonka, Matko Cerar, Vasilij, Dolžan, Vita, Steblovnik, Lili, Lučovnik, Miha, Novak Antolič, Živa
The influence of genetic variability on the risk of developing malignant mesothelioma
Article

The influence of genetic variability on the risk of developing malignant mesothelioma

Franko, Alenka, Kotnik, Nika, Goricar, Katja, Kovac, Viljem, Dodic-Fikfak, Metoda, Dolzan, Vita
The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma
Article

The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma

Piber, Petra, Vavpetic, Neza, Goricar, Katja, Dolzan, Vita, Kovac, Viljem, Franko, Alenka